查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1847812

乳房切片市場按技術、手術類型和最終用戶分類 - 全球預測 2025-2032

Breast Biopsy Market by Technology, Procedure Type, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，乳房切片市場規模將達到 22.7 億美元，複合年成長率為 9.55%。

主要市場統計數據
基準年 2024 10.9億美元
預計年份：2025年 12億美元
預測年份：2032年 22.7億美元
複合年成長率 (%) 9.55%

建構以病人為中心的乳房切片綜合觀點，將臨床結果、器材創新和機構策略結合

乳房疾病的診斷依賴於及時、準確且微創的組織取樣。影像學和儀器技術的進步豐富了臨床醫生可選擇的切片檢查方式，而患者對安全性和舒適度的期望也正在改變手術流程的優先順序。因此，醫療決策者、製造商和臨床團隊必須在多種醫療環境中，平衡日益成長的精準度需求與實際操作限制。

本出版物透過概述技術、臨床實踐和醫療保健系統交付之間不斷演變的相互關係，建構了一個更深層的分析框架。它重點強調了對手術個體化、跨部門協作和數據主導的品質保證日益成長的重視。此外，它還著重闡述了監管機構對器械安全性和療效比較的關注如何重塑產品開發週期和應用管道。接下來的章節將從臨床結果、效率和病人體驗的角度出發，探討這個主題對價值鏈上相關人員的策略意義。

影像技術的進步、設備的模組化以及以患者為中心的服務模式如何重塑乳房切片護理的臨床工作流程和採購重點

乳房切片領域正經歷顯著的變革，這主要得益於技術小型化、影像技術的整合以及對以患者為中心的工作流程的重新重視。高解析度超音波和先進的磁振造影序列等顯像模式正變得越來越普及和易於互操作，使臨床醫生能夠更精準地定位病灶並縮短手術時間。同時，設備製造商也朝著模組化設計方向發展，優先考慮人體工學、即時回饋以及與多種成像平台的兼容性。

這種轉變也體現在醫療服務模式中。由於效率和便利性，門診和流動醫療機構擴大進行以往僅在住院機構進行的複雜診斷程序。同時，臨床路徑強調共同共用，並要求就切片檢查的風險、益處和預期診斷價值進行更清晰的溝通。總而言之，這些趨勢正在重塑採購重點、操作人員培訓要求和供應商合作模式，為願意適應的相關人員創造新的機會和競爭壓力。

評估2025年關稅調整的影響，以及相關人員如何調整其採購策略，進而影響下游營運和供應鏈。

改變醫療設備採購和臨床報銷經濟模式的政策措施可能會對整個供應鏈和醫療保健系統產生連鎖反應。 2025年實施的關稅調整帶來了成本壓力，影響了採購決策、定價策略和庫存管理的地理佈局。採購團隊的因應措施包括重新評估供應商多樣性、最佳化物流以及尋求合約保護以降低跨境關稅波動帶來的風險。

同時，製造商評估了製造地和售後支援模式，以確保利潤率並確保供應的連續性。在這些調整過程中，合規性和品質保證仍然是重中之重，促使製造商加強對國內組裝和高效分銷管道的投資。臨床醫生和醫療系統領導者透過重新審視病例組合和排班模式來適應變化，從而在不影響醫療服務可及性的前提下消化單位成本的上漲。最後，關稅環境凸顯了靈活的籌資策略和積極的商業規劃對於在不斷變化的貿易環境中維持服務水準的重要性。

透過對設備技術、手術方式和最終用戶環境進行詳細的細分分析，提供有針對性的商業化和臨床應用策略。

細分市場洞察揭示了因技術、手術類型和終端用戶環境而異的細微需求促進因素，因此需要差異化的商業和臨床策略。按技術粗針穿刺切片設備在手術選擇中佔據重要佔有率，並提供自動化和半自動化配置，以平衡通量和操作者控制。細針穿刺針包括適用於細胞學工作流程的標準針頭，以及用於超音波視覺化效果的迴聲增強型針頭。真空輔助系統分為兩類：一類是專為照護現場主導而最佳化的手持式設備，另一類是專為複雜病灶和高流量環境而設計的桌上型平台。

對手術類型進行細分，有助於更清晰地確定設備選擇和培訓的優先順序。 MRI導引手術根據封閉式和開放式系統進行區分，每種系統都需要考慮病灶的可見性和患者的耐受性。觸診導引手術仍然是可行的選擇，包括徒手觸診和在影像訪問受限時使用的網格導引手術。立體定位切片檢查可在俯臥和直立位下進行，這會影響患者體位、成像幾何形狀和手術時間。超音波引導介入手術因2D和新興的3D成像技術而異，這會影響靶向精度和操作者的學習曲線。最後，最終用戶細分揭示了需求集中在哪裡以及採購和營運標準有何不同：門診手術中心（包括診斷中心和門診手術中心）優先考慮的是每次手術的吞吐量和成本效益；私立和公立醫院強調的是全面的服務組合和強大的庫存支持；而專科診所（例如腫瘤科和放射科診所）則強調臨床專業知識、綜合診斷和患者導航。這些細分揭示了創新、服務模式和商業性合作將在哪些方面產生最大的策略影響。

美洲、中東和非洲以及亞太地區的區域動態和策略考慮將影響招募、分銷和臨床支援優先事項。

區域動態影響臨床實踐模式和商業性需求，而從地理角度出發的細緻觀點有助於相關人員優先考慮市場准入、分銷和支持性投資。在美洲，醫療系統強調以價值為導向的醫療服務、提高手術效率和擴大門診病人服務，從而催生了對易於使用的設備和整合工作流程解決方案的需求。該地區的報銷機制和醫院採購流程往往傾向於選擇已證實具有臨床療效和完善的上市後支援的產品。

歐洲、中東和非洲地區管理體制的多樣性和基礎設施的差異，造就了機會與挑戰並存的局面。該地區部分市場正迅速採用先進的影像和設備平台，而其他市場則優先考慮成本效益高、可擴展的解決方案，以便應用於各種醫療環境。在地化生產、監管協調和培訓夥伴關係往往是勝利的關鍵因素。在亞太地區，醫院的快速現代化和篩檢計畫的增加推動了對精準切片檢查解決方案的需求，而市場參與企業必須應對當地的監管管道、分銷網路以及臨床醫生培訓需求，才能實現持續的市場應用。了解這些區域特徵，有助於製造商和醫療系統規劃者調整產品系列、商業模式和支援服務，從而最大限度地提高臨床和營運的相關性。

競爭格局和企業層面的策略訊號強調透過整合解決方案、臨床夥伴關係和卓越服務實現差異化。

乳房切片生態系統的競爭動態以技術差異化、服務主導的價值提案和策略協同為特徵。領先的設備開發人員正日益將硬體與數位化工具相結合，以增強手術規劃、文件記錄和術後追蹤。因此，能夠提供涵蓋設備可靠性、影像互通性和資料整合等端到端解決方案的公司，更有利於建立長期的合作關係。

設備製造商、影像供應商和臨床中心之間的夥伴關係能夠加速創新週期，並支援臨床檢驗工作流程的開發。此外，供應鏈的韌性、對監管的應對力以及卓越的服務是醫院系統和專科診所的關鍵考慮因素。新參與企業往往透過專注於人體工學設計和一次性組件等細分領域的創新來獲得初期發展動力，而參與企業則利用其規模、全球分銷和臨床證據來鞏固市場地位。最終，在競爭格局中，那些投資於臨床醫生培訓、市場研究和基於結果的有效證據的機構將獲得回報。

為製造商和醫療系統提供切實可行的策略指南，以協調創新、賦能和供應鏈韌性，從而加速產品應用和價值實現。

行業領導者應採取平衡策略，將產品創新、營運支援和臨床醫生賦能相結合，以加速產品普及並保持價值。首先，優先考慮能夠提升操作人體工學和影像相容性，同時降低設定複雜性的設備設計。其次，投資臨床醫生教育計畫和基於模擬的培訓，以提高操作一致性並支持品質指標。第三，拓展服務範圍，使其超越硬體本身，涵蓋操作流程諮詢、遠端故障排除和結果追蹤工具，從而建立更牢固的客戶關係。

此外，應拓展供應鏈選擇，將本地組裝與戰略庫存中心結合，以降低關稅和物流相關的干擾。與影像供應商和專科診所合作，檢驗整合工作流程，並創建能夠引起支付方和採購委員會共鳴的真實案例。最後，採用靈活的商業模式，從按次計費的耗材定價到捆綁式解決方案契約，以滿足不同客戶的預算需求，並加速在門診、住院和專科護理機構的推廣應用。這些措施相結合，能夠幫助機構將創新轉化為可衡量的臨床和商業性效益。

結合文獻綜述、臨床醫師訪談和資料三角驗證的多源資訊來源調查方法，檢驗策略性見解並減少分析限制。

我們的調查方法以結構化和透明的方式綜合證據，旨在確保分析的嚴謹性和實際應用價值。此方法首先對同行評審的臨床文獻、監管文件和器械技術文件進行全面審查，以建立對安全性、手術適應症和器械特性的基本了解。隨後進行定性研究，包括對介入放射科醫生、乳房外科醫生、採購負責人和器械工程師的訪談，以揭示實際應用中的促進因素、障礙和未滿足的需求。

資料三角驗證確保了主要來源和次要來源之間的一致性，與臨床顧問舉行的檢驗研討會完善了解讀並確定了策略意義的優先順序。調查方法方法包括設備功能比較映射、流程路徑分析和供應鏈風險評估。研究指出了方法學上的局限性，例如實踐模式的區域差異和不斷發展的影像技術，並描述了相應的緩解措施，包括專家選擇性抽樣和敏感性檢定。倫理方面的考量包括保密性、所有訪談均需獲得知情同意，以及對從業人員資料進行匿名化處理以保護專家隱私。

整合策略要務，闡明臨床證據、商業敏捷性和營運韌性如何決定乳房切片護理的長期成功

臨床趨勢、技術進步和營運實際情況的綜合表明，近期面臨的挑戰在於，精準度、患者體驗和供應鏈韌性這三者相互交織，成為成功的關鍵決定因素。如果能夠提供強力的培訓和服務支持，那麼在目標精準度、人體工學和與影像系統互通性方面具有顯著改進的設備很可能獲得臨床認可。同時，醫療系統將繼續優先考慮手術量和成本控制，從而催生對可在門診和住院環境中部署的模組化解決方案的需求。

總之，整合臨床證據產生、靈活商業模式和穩健供應鏈策略的相關人員將更有利於創造價值並改善病患療效。隨著這一格局的演變，與臨床醫生持續互動、大力投資上市後證據以及製定適應性強的商業計劃，對於保持發展勢頭並將創新轉化為日常實踐仍然至關重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合人工智慧和深度學習技術，提高切片檢查靶向的準確性和效率
  • 採用微創真空輔助切片檢查系統，以提高患者舒適度並縮短手術時間
  • 增加造影增強數位乳房斷層合成導引切片檢查的使用，以提高病灶視覺化效果和樣本採集準確性
  • 新興的液態生物檢體技術可與全面的分子分析和組織取樣相結合，用於早期檢測。
  • 開發可攜式即時檢測設備，以實現分散式診斷和快速臨床決策。
  • 引入即時離體共聚焦顯微鏡，可實現即時組織評估並降低重複活體組織切片率
  • 擴展的機器人輔助乳房切片平台提高了手術的一致性，並減少了操作者之間的差異。
  • 不斷變化的醫保報銷政策和法規結構正在推動全球先進乳房切片技術的普及。

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章乳房切片市場（依技術分類）

  • 核心針切片裝置
    • 自動穿刺切片裝置
    • 半自動穿刺切片裝置
  • 細針吸針
    • 超音波增強細針穿刺
    • 標準細針穿刺針
  • 真空輔助系統
    • 手持真空輔助
    • 工作台配置真空輔助

第9章 依手術類型分類的乳房切片市場

  • MRI 指南
    • 封閉式
    • 開膛式
  • 觸診指南
    • 徒手觸診
    • 網格指南
  • 切片檢查定位活體組織切片
    • 俯臥立體定位放射治療
    • 直立姿勢
  • 超音波引導
    • 2D超音波引導
    • 3D超音波引導

第10章乳房切片市場（按最終用戶分類）

  • 門診病人手術中心
    • 診斷中心
    • 門診手術中心
  • 醫院
    • 私立醫院
    • 公立醫院
  • 專科診所
    • 腫瘤診所
    • 放射科診所

第11章 各地區乳房切片市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章乳房切片市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 各國乳房切片市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Hologic, Inc.
    • Becton Dickinson and Company
    • General Electric Company
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Cook Medical, Inc.
    • Merit Medical Systems, Inc.
    • Cardinal Health, Inc.
    • Medtronic plc
Product Code: MRR-4F4C36263235

The Breast Biopsy Market is projected to grow by USD 2.27 billion at a CAGR of 9.55% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.09 billion
Estimated Year [2025] USD 1.20 billion
Forecast Year [2032] USD 2.27 billion
CAGR (%) 9.55%

Setting the stage for an integrated and patient-centered view of breast biopsy care that connects clinical outcomes, device innovation, and institutional strategy

The diagnostic pathway for breast disease hinges on timely, accurate, and minimally invasive tissue sampling. Advances in imaging and device engineering have diversified the array of biopsy options available to clinicians, while patient expectations for safety and comfort have shifted procedural priorities. Consequently, institutional decision-makers, manufacturers, and clinical teams must reconcile rising demand for precision with operational constraints in multiple care settings.

This introduction establishes the context for deeper analysis by outlining the evolving intersections of technology, clinical practice, and health system delivery. It highlights the growing emphasis on procedure personalization, cross-disciplinary collaboration, and data-driven quality assurance. Moreover, it underscores how regulatory emphasis on device safety and comparative effectiveness is reshaping product development cycles and adoption pathways. By framing the topic in terms of clinical outcomes, throughput, and patient experience, the subsequent sections will explore the strategic implications for stakeholders across the value chain.

How converging imaging advances, device modularity, and patient-centered delivery models are reshaping clinical workflows and procurement priorities in breast biopsy care

The landscape for breast biopsy is undergoing transformative shifts driven by technological miniaturization, imaging convergence, and a renewed focus on patient-centric workflows. Imaging modalities such as high-resolution ultrasound and advanced MRI sequences have become more accessible and interoperable, enabling clinicians to target lesions with greater accuracy and reduced procedure time. At the same time, device manufacturers have converged on modular designs that prioritize ergonomics, real-time feedback, and compatibility with multiple imaging platforms.

These shifts are also reflected in care delivery models: outpatient and ambulatory environments increasingly perform diagnostically complex procedures previously restricted to inpatient settings, driven by efficiency and patient convenience. Meanwhile, clinical pathways emphasize shared decision-making, which requires clearer communication of biopsy risks, benefits, and expected diagnostic value. Taken together, these trends are rewriting procurement priorities, operator training requirements, and vendor collaborations, creating new opportunities and competitive pressures for stakeholders prepared to adapt.

Assessing the downstream operational and supply chain consequences of tariff adjustments during 2025 and how stakeholders realigned sourcing and procurement strategies

Policy instruments that alter the economic calculus of device procurement and clinical reimbursement can produce ripple effects throughout the supply chain and care continuum. Tariff adjustments implemented in 2025 introduced discrete cost pressures that influenced sourcing decisions, pricing strategies, and the geographic orientation of inventory management. Procurement teams responded by reassessing supplier diversity, optimizing logistics, and seeking contractual protections that mitigate exposure to cross-border tariff volatility.

In parallel, manufacturers evaluated their manufacturing footprints and aftermarket support models to preserve margin and ensure continuity of supply. Regulatory compliance and quality assurance remained top priorities during these adjustments, prompting incremental investments in domestic assembly and validated distribution channels. Clinicians and health system leaders adapted by reexamining case mix and scheduling patterns to absorb incremental unit costs without compromising access. Ultimately, the tariff environment underscored the importance of flexible sourcing strategies and proactive commercial planning to sustain service levels amid shifting trade conditions.

Detailed segmentation analysis across device technologies, procedural modalities, and end-user settings to inform targeted commercialization and clinical adoption strategies

Segmentation insights reveal nuanced demand drivers that vary across technology, procedure type, and end-user settings and therefore require differentiated commercial and clinical strategies. Within technology, Core Needle Biopsy Devices account for a substantial portion of procedural choices and are available in automated and semi-automated configurations that balance throughput with operator control. Fine Needle Aspiration Needles include echo-enhanced variants for improved sonographic visualization alongside standard needles that remain relevant for cytology-driven workflows. Vacuum-Assisted Systems present a bifurcated product set with handheld devices optimized for point-of-care convenience and table-configured platforms designed for complex lesion access and high-volume environments.

Procedure-type segmentation further informs device selection and training priorities. MRI-guided approaches are differentiated by closed-bore and open-bore systems, each aligning with specific lesion visibility and patient tolerance considerations. Palpation-guided procedures persist as pragmatic options through freehand palpation and grid-guided techniques where imaging access is limited. Stereotactic biopsies comprise prone and upright configurations, which influence patient positioning, imaging geometry, and procedure time. Ultrasound-guided interventions vary between 2D and emerging 3D imaging capabilities, which affect targeting precision and operator learning curves. Finally, end-user segmentation clarifies where demand concentrates and how procurement and operational criteria diverge: Ambulatory Surgery Centers, including diagnostic centers and outpatient surgery centers, prioritize throughput and per-procedure cost-efficiency; Hospitals, spanning private and public institutions, emphasize comprehensive service portfolios and robust inventory support; Specialty Clinics, such as oncology and radiology clinics, focus on clinical specialization, integrated diagnostics, and patient navigation. Together, these segmentation lenses illuminate where innovation, service models, and commercial engagement will have the highest strategic impact.

Regional dynamics and strategic considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence adoption, distribution, and clinical support priorities

Regional dynamics shape both clinical practice patterns and commercial imperatives, and a geographically nuanced view helps stakeholders prioritize market entry, distribution, and support investments. In the Americas, health systems emphasize value-based care, procedural efficiency, and outpatient expansion, creating demand for user-friendly devices and integrated workflow solutions. Reimbursement mechanisms and hospital procurement processes in this region tend to favor demonstrable clinical benefit and robust post-market support.

In Europe, Middle East & Africa, diverse regulatory regimes and heterogeneous infrastructure create a mosaic of opportunity and constraint. Some markets in this region adopt advanced imaging and device platforms rapidly, while others prioritize cost-effective, scalable solutions that can be deployed across variable care settings. Local manufacturing, regulatory harmonization, and training partnerships often become differentiators. Asia-Pacific presents a broad spectrum of adoption trajectories where rapid hospital modernization and rising screening programs drive demand for precision biopsy solutions; meanwhile, market entrants must navigate local regulatory pathways, distribution networks, and clinician training needs to realize sustainable uptake. Understanding these regional contours allows manufacturers and health system planners to tailor product portfolios, commercial models, and support services for maximal clinical and operational relevance.

Competitive landscape and company-level strategic signals highlighting differentiation through integrated solutions, clinical partnerships, and service excellence

Competitive dynamics in the breast biopsy ecosystem are characterized by technology differentiation, service-led value propositions, and strategic collaboration. Leading device developers increasingly couple hardware offerings with digital tools that enhance procedural planning, documentation, and post-procedure tracking. As a result, companies that can demonstrate end-to-end solutions-combining device reliability, imaging interoperability, and data integration-are better positioned to secure long-term institutional relationships.

Partnerships between device manufacturers, imaging vendors, and clinical centers accelerate innovation cycles and support the development of clinically validated workflows. Moreover, supply chain resilience, regulatory responsiveness, and service excellence serve as critical decision criteria for hospital systems and specialty clinics. New entrants tend to focus on niche innovations-such as ergonomic designs or disposable components-to gain initial traction, while established players leverage scale, global distribution networks, and clinical evidence to defend market positions. Ultimately, the competitive landscape rewards organizations that invest in clinician training, post-market surveillance, and meaningful outcome-based evidence.

Actionable strategic playbook for manufacturers and health systems to align innovation, enablement, and supply chain resilience to accelerate adoption and value realization

Industry leaders should pursue a balanced strategy that aligns product innovation with operational support and clinician enablement to accelerate adoption and sustain value. First, prioritize device designs that enhance procedural ergonomics and imaging compatibility while reducing setup complexity; this approach shortens learning curves and improves throughput. Second, invest in clinician education programs and simulation-based training that reinforce technique consistency and support quality metrics. Third, expand service offerings beyond hardware to include procedural workflow consulting, remote troubleshooting, and outcome-tracking tools that create stickier customer relationships.

Furthermore, diversify supply chain options to mitigate tariff and logistics-related disruptions by combining localized assembly with strategic inventory hubs. Forge partnerships with imaging vendors and specialty clinics to validate integrated workflows and produce real-world evidence that resonates with payers and procurement committees. Lastly, adopt flexible commercial models-ranging from per-procedure consumable pricing to bundled solution contracts-to accommodate diverse customer budgets and accelerate adoption across ambulatory, hospital, and specialty settings. These combined actions will help organizations translate innovation into measurable clinical and commercial gains.

Robust, multi-source research methodology combining literature synthesis, clinician interviews, and data triangulation to validate strategic insights and mitigate analytical limitations

This research synthesizes evidence from a structured and transparent methodology designed to ensure analytical rigor and practical relevance. The approach began with a comprehensive review of peer-reviewed clinical literature, regulatory filings, and technical device documentation to establish a baseline understanding of safety profiles, procedural indications, and device characteristics. Next, qualitative primary research included interviews with practicing interventional radiologists, breast surgeons, procurement leaders, and device engineers to surface real-world adoption drivers, barriers, and unmet needs.

Data triangulation ensured consistency between primary insights and secondary sources, and validation workshops with clinical advisors refined interpretations and prioritized strategic implications. Analytical methods included comparative device feature mapping, procedural pathway analysis, and supply chain risk assessment. The research also documents methodological limitations, such as variability in practice patterns across regions and the evolving nature of imaging technology, and describes mitigation strategies like purposive sampling of experts and sensitivity checks. Ethical considerations governed confidentiality, informed consent for all interviews, and anonymization of practitioner-level data to preserve professional privacy.

Synthesis of strategic imperatives showing how clinical evidence, commercialization agility, and operational resilience will determine long-term success in breast biopsy care

The synthesis of clinical trends, technological progress, and operational realities points to a near-term agenda where precision, patient experience, and supply chain resilience intersect as primary determinants of success. Devices that offer clear improvements in targeting accuracy, ergonomics, and interoperability with imaging systems will find receptive clinical audiences when supported by robust training and service commitments. Meanwhile, health systems will continue to emphasize procedural throughput and cost control, creating demand for modular solutions that can be deployed across ambulatory and hospital settings.

In summary, stakeholders that integrate clinical evidence generation, flexible commercial models, and resilient supply strategies will be best positioned to capture value and improve patient outcomes. As the landscape evolves, continuous engagement with clinicians, proactive investment in post-market evidence, and adaptive commercial planning will remain essential to sustaining momentum and translating innovation into routine practice.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence and deep learning for improved biopsy targeting accuracy and efficiency
  • 5.2. Adoption of minimally invasive vacuum-assisted biopsy systems for enhanced patient comfort and reduced procedure times
  • 5.3. Growing use of contrast-enhanced digital breast tomosynthesis guided biopsies to improve lesion visualization and sampling precision
  • 5.4. Emergence of liquid biopsy techniques complementing tissue sampling for comprehensive molecular profiling and early detection
  • 5.5. Development of portable point-of-care breast biopsy devices enabling decentralized diagnostics and faster clinical decision making
  • 5.6. Implementation of real-time ex vivo confocal microscopy to provide immediate tissue assessment and reduce repeat biopsy rates
  • 5.7. Expansion of robotic-assisted breast biopsy platforms to increase procedural consistency and limit operator variability
  • 5.8. Evolving reimbursement policies and regulatory frameworks driving adoption rates of advanced breast biopsy technologies globally

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Breast Biopsy Market, by Technology

  • 8.1. Core Needle Biopsy Devices
    • 8.1.1. Automated Core Needle Biopsy Devices
    • 8.1.2. Semi-Automated Core Needle Biopsy Devices
  • 8.2. Fine Needle Aspiration Needles
    • 8.2.1. Echo Enhanced FNA Needles
    • 8.2.2. Standard FNA Needles
  • 8.3. Vacuum-Assisted Systems
    • 8.3.1. Handheld Vacuum-Assisted
    • 8.3.2. Table Configured Vacuum-Assisted

9. Breast Biopsy Market, by Procedure Type

  • 9.1. MRI Guided
    • 9.1.1. Closed Bore
    • 9.1.2. Open Bore
  • 9.2. Palpation Guided
    • 9.2.1. Freehand Palpation
    • 9.2.2. Grid Guided
  • 9.3. Stereotactic
    • 9.3.1. Prone Stereotactic
    • 9.3.2. Upright Stereotactic
  • 9.4. Ultrasound Guided
    • 9.4.1. 2D Ultrasound Guided
    • 9.4.2. 3D Ultrasound Guided

10. Breast Biopsy Market, by End User

  • 10.1. Ambulatory Surgery Centers
    • 10.1.1. Diagnostic Centers
    • 10.1.2. Outpatient Surgery Centers
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals
  • 10.3. Specialty Clinics
    • 10.3.1. Oncology Clinics
    • 10.3.2. Radiology Clinics

11. Breast Biopsy Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Breast Biopsy Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Breast Biopsy Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Hologic, Inc.
    • 14.3.2. Becton Dickinson and Company
    • 14.3.3. General Electric Company
    • 14.3.4. Siemens Healthineers AG
    • 14.3.5. Koninklijke Philips N.V.
    • 14.3.6. Canon Medical Systems Corporation
    • 14.3.7. Cook Medical, Inc.
    • 14.3.8. Merit Medical Systems, Inc.
    • 14.3.9. Cardinal Health, Inc.
    • 14.3.10. Medtronic plc

LIST OF FIGURES

  • FIGURE 1. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BREAST BIOPSY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. BREAST BIOPSY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BREAST BIOPSY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BREAST BIOPSY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BREAST BIOPSY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BREAST BIOPSY MARKET SIZE, BY AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BREAST BIOPSY MARKET SIZE, BY SEMI-AUTOMATED CORE NEEDLE BIOPSY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BREAST BIOPSY MARKET SIZE, BY ECHO ENHANCED FNA NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BREAST BIOPSY MARKET SIZE, BY STANDARD FNA NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BREAST BIOPSY MARKET SIZE, BY HANDHELD VACUUM-ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BREAST BIOPSY MARKET SIZE, BY TABLE CONFIGURED VACUUM-ASSISTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BREAST BIOPSY MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BREAST BIOPSY MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BREAST BIOPSY MARKET SIZE, BY FREEHAND PALPATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BREAST BIOPSY MARKET SIZE, BY GRID GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRONE STEREOTACTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BREAST BIOPSY MARKET SIZE, BY UPRIGHT STEREOTACTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BREAST BIOPSY MARKET SIZE, BY 2D ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BREAST BIOPSY MARKET SIZE, BY 3D ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BREAST BIOPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BREAST BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BREAST BIOPSY MARKET SIZE, BY OUTPATIENT SURGERY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BREAST BIOPSY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BREAST BIOPSY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BREAST BIOPSY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BREAST BIOPSY MARKET SIZE, BY ONCOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BREAST BIOPSY MARKET SIZE, BY RADIOLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BREAST BIOPSY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS BREAST BIOPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 295. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 296. LATIN AMERICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY CORE NEEDLE BIOPSY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY FINE NEEDLE ASPIRATION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY VACUUM-ASSISTED SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY MRI GUIDED, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY PALPATION GUIDED, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY STEREOTACTIC, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY ULTRASOUND GUIDED, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA BREAST BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE BREAST BIOPSY MARK